遠東宏信(03360.HK):前三季度純利同比提升超20%
格隆匯10月21日丨遠東宏信(03360.HK)發佈公吿,2021年第三季度,回顧期內,中國經濟總體保持恢復態勢,但國內外環境仍然嚴峻多變。面對複雜的外部環境,集團一如既往恪守本質、不斷提升經營內涵,從而繼續保持了持續、穩定、健康的發展態勢。截至前三季度,集團營業收入同比提升略超20%,歸屬普通股股東應占溢利同比提升微超20%;財務結構持續優化,產業業務收入佔比超30%。
集團將繼續秉承“金融+產業”的發展戰略,憑藉長期沉澱並不斷增強的龐大客户基礎及專業運營能力,在不確定的外部環境下,力爭實現2021年全年穩健發展的經營結果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.